Skip to main content

Advertisement

Table 1 Clinicopathological characteristics of the patients

From: Distinct patterns and prognostic values of tumor-infiltrating macrophages in hepatocellular carcinoma and gastric cancer

Variables No. and (%)
HCC patients
No. of patients 188
Age (median; range), years 50; 13–76
Gender (male/female) 159/29 (84.6/15.4)
HBV infection (no/yes) 19/169 (10.1/89.9)
Alpha-fetoprotein, ng/mL (≤2 5/>25) 74/114 (39.4/60.6)
Child–Pugh class (A/B) 175/13 (93.1/6.9)
Tumor number (single/multiple) 144/44 (76.6/23.4)
Tumor size, cm (≤5/>5) 80/108 (42.6/57.4)
Vascular invasion (absent/present) 177/11 (94.1/5.9)
TNM stage (I/II/III) 130/16/39 (69.1/10.1/20.8)
Histological grade (I/II/III/other) 125/63 (66.5/33.5)
GC patients
No. of patients 138
Age (median; range), years 69; 28–78
Gender (male/female) 100/38 (72.5/27.5)
Tumor size, cm (≤4/>4) 46/92 (33.3/66.7)
Tumor depth (pT1/pT2/pT3/pT4) 3/10/34/91 (2.2/7.2/24.7/65.9)
Lymph node metastasis (pN0/pN1/pN2/pN3) 29/31/27/51 (21.0/22.5/19.5/37.0)
TNM stage (IA/IB/II/IIIA/IIIB/IIIC) 3/6/5/25/32/32/35 (2.2/4.3/3.6/18.1/23.2/23.2/25.4)
Histological grade (I/II/III/other) 3/32/90/11 (2.2/23.2/65.2/8.0)
  1. HCC hepatocellular carcinoma, GC gastric cancer, HBV hepatitis B virus, TNM tumor-lymph node-metastasis